IBDEI0CL ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5630,1,3,0)
 ;;=3^428.1
 ;;^UTILITY(U,$J,358.3,5630,1,4,0)
 ;;=4^LEFT HEART FAILURE
 ;;^UTILITY(U,$J,358.3,5630,2)
 ;;=^68721
 ;;^UTILITY(U,$J,358.3,5631,0)
 ;;=581.9^^28^371^17
 ;;^UTILITY(U,$J,358.3,5631,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5631,1,3,0)
 ;;=3^581.9
 ;;^UTILITY(U,$J,358.3,5631,1,4,0)
 ;;=4^NEPHROTIC SYNDROME NOS
 ;;^UTILITY(U,$J,358.3,5631,2)
 ;;=^82357
 ;;^UTILITY(U,$J,358.3,5632,0)
 ;;=278.01^^28^371^18
 ;;^UTILITY(U,$J,358.3,5632,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5632,1,3,0)
 ;;=3^278.01
 ;;^UTILITY(U,$J,358.3,5632,1,4,0)
 ;;=4^OBESITY,MORBID
 ;;^UTILITY(U,$J,358.3,5632,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,5633,0)
 ;;=278.00^^28^371^19
 ;;^UTILITY(U,$J,358.3,5633,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5633,1,3,0)
 ;;=3^278.00
 ;;^UTILITY(U,$J,358.3,5633,1,4,0)
 ;;=4^OBESITY,UNSPEC
 ;;^UTILITY(U,$J,358.3,5633,2)
 ;;=^84823
 ;;^UTILITY(U,$J,358.3,5634,0)
 ;;=278.02^^28^371^20
 ;;^UTILITY(U,$J,358.3,5634,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5634,1,3,0)
 ;;=3^278.02
 ;;^UTILITY(U,$J,358.3,5634,1,4,0)
 ;;=4^OVERWEIGHT
 ;;^UTILITY(U,$J,358.3,5634,2)
 ;;=^332745
 ;;^UTILITY(U,$J,358.3,5635,0)
 ;;=423.9^^28^371^21
 ;;^UTILITY(U,$J,358.3,5635,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5635,1,3,0)
 ;;=3^423.9
 ;;^UTILITY(U,$J,358.3,5635,1,4,0)
 ;;=4^PERICARDIAL DISEASE NOS
 ;;^UTILITY(U,$J,358.3,5635,2)
 ;;=^123813
 ;;^UTILITY(U,$J,358.3,5636,0)
 ;;=443.9^^28^371^22
 ;;^UTILITY(U,$J,358.3,5636,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5636,1,3,0)
 ;;=3^443.9
 ;;^UTILITY(U,$J,358.3,5636,1,4,0)
 ;;=4^PERIPH VASCULAR DIS NOS
 ;;^UTILITY(U,$J,358.3,5636,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,5637,0)
 ;;=272.0^^28^371^23
 ;;^UTILITY(U,$J,358.3,5637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5637,1,3,0)
 ;;=3^272.0
 ;;^UTILITY(U,$J,358.3,5637,1,4,0)
 ;;=4^PURE HYPERCHOLESTEROLEM
 ;;^UTILITY(U,$J,358.3,5637,2)
 ;;=^59973
 ;;^UTILITY(U,$J,358.3,5638,0)
 ;;=272.1^^28^371^24
 ;;^UTILITY(U,$J,358.3,5638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5638,1,3,0)
 ;;=3^272.1
 ;;^UTILITY(U,$J,358.3,5638,1,4,0)
 ;;=4^PURE HYPERGLYCERIDEMIA
 ;;^UTILITY(U,$J,358.3,5638,2)
 ;;=^101303
 ;;^UTILITY(U,$J,358.3,5639,0)
 ;;=588.0^^28^371^25
 ;;^UTILITY(U,$J,358.3,5639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5639,1,3,0)
 ;;=3^588.0
 ;;^UTILITY(U,$J,358.3,5639,1,4,0)
 ;;=4^RENAL OSTEODYSTROPHY
 ;;^UTILITY(U,$J,358.3,5639,2)
 ;;=^104747
 ;;^UTILITY(U,$J,358.3,5640,0)
 ;;=589.0^^28^371^26
 ;;^UTILITY(U,$J,358.3,5640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5640,1,3,0)
 ;;=3^589.0
 ;;^UTILITY(U,$J,358.3,5640,1,4,0)
 ;;=4^UNILATERAL SMALL KIDNEY
 ;;^UTILITY(U,$J,358.3,5640,2)
 ;;=^270363
 ;;^UTILITY(U,$J,358.3,5641,0)
 ;;=593.2^^28^372^1
 ;;^UTILITY(U,$J,358.3,5641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5641,1,3,0)
 ;;=3^593.2
 ;;^UTILITY(U,$J,358.3,5641,1,4,0)
 ;;=4^CYST OF KIDNEY, ACQUIRED
 ;;^UTILITY(U,$J,358.3,5641,2)
 ;;=^270380
 ;;^UTILITY(U,$J,358.3,5642,0)
 ;;=753.10^^28^372^2
 ;;^UTILITY(U,$J,358.3,5642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5642,1,3,0)
 ;;=3^753.10
 ;;^UTILITY(U,$J,358.3,5642,1,4,0)
 ;;=4^CYSTIC KIDNEY DISEASE, UNSPEC
 ;;^UTILITY(U,$J,358.3,5642,2)
 ;;=^104720
 ;;^UTILITY(U,$J,358.3,5643,0)
 ;;=753.17^^28^372^3
 ;;^UTILITY(U,$J,358.3,5643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5643,1,3,0)
 ;;=3^753.17
 ;;^UTILITY(U,$J,358.3,5643,1,4,0)
 ;;=4^MEDULLARY SPONGE KIDNEY
 ;;^UTILITY(U,$J,358.3,5643,2)
 ;;=^67302
 ;;^UTILITY(U,$J,358.3,5644,0)
 ;;=753.13^^28^372^4
 ;;^UTILITY(U,$J,358.3,5644,1,0)
 ;;=^358.31IA^4^2
 ;;
 ;;$END ROU IBDEI0CL
